The North America Corneal Implants Market would witness market growth of 5.7% CAGR during the forecast period (2023-2029).
Bioengineered corneal implants are made using tissue engineering techniques to produce corneal implants from living cells. These implants may provide greater biocompatibility, a lower risk of problems, and better visual outcomes when compared to conventional synthetic implants.
Thus, the development of cutting-edge technologies is anticipated to fuel the expansion of the corneal implants market throughout the anticipated period. The market for corneal implants is also expected to grow due to rising demand for corneal transplants, better healthcare infrastructure, and prospects in developing nations. Also, there has been a huge increase in public knowledge of corneal transplantation, which spurs the market's expansion.
In the US, 4% of adults over the age of 40 have the late-onset variant of Fuchs endothelial dystrophy, which is a frequent disorder. The exact prevalence of the early-onset Fuchs endothelial dystrophy variety is yet unknown. However, for unknown reasons, women are two to four times more likely than men to develop Fuchs endothelial dystrophy. In addition, Fuchs endothelial dystrophy is uncertain in its genetics. The development of Fuchs endothelial dystrophy is thought to be influenced by various genes and areas found within a few chromosomes. Thus, these factors are propelling the market growth in the North America region.
The US market dominated the North America Corneal Implants Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $173.2 million by 2029. The Canada market is poised to grow at a CAGR of 8.2% during (2023 - 2029). Additionally, The Mexico market would witness a CAGR of 7.2% during (2023 - 2029).
Based on Disease Type, the market is segmented into Fuchs' Dystrophy, Keratoconus, Infectious Keratitis and Others. Based on Procedure Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, and Others. Based on End User, the market is segmented into Hospitals, Ophthalmic Centers and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Corneal Implants Market is Projected to reach USD 595.1 Million by 2029, at a CAGR of 6.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Presbia PLC, CorNeat Vision Ltd., Alcon, Inc., AJL Opthalmic SA, LinkoCare Life Sciences AB, CorneaGen, DIOPTEX GmbH, Mediphacos Industrias Medicas S.A., EyeYon Medical Ltd., and KeraMed, Inc.
By Disease Type
By Procedure Type
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 